Standardization of imaging reads for eligibility assessment of patients—component of a risk mitigation strategy in the tanezumab clinical program
Roemer, F.W, Miller, C.G, West, C.R, Sherlock, S.P, Brown, M.T, Kompel, A.J, Diaz, L, Galante, N, Crema, M.D, Guermazi, A
Published in Osteoarthritis and cartilage (01.04.2017)
Published in Osteoarthritis and cartilage (01.04.2017)
Get full text
Journal Article
201 Bone safety data in adolescents with moderate-to-severe atopic dermatitis treated with abrocitinib: interim results from the JADE EXTEND MRI substudy
Zdybski, J., Wollenberg, A., Flohr, C., Brunner, P.M., Högler, W., Egeberg, A., Irvine, A.D., Fan, H., Biswas, P., Radi, Z., Farooqui, S.A., Koppensteiner, H., Sherlock, S.P., Chan, G.
Published in Journal of investigative dermatology (01.11.2023)
Published in Journal of investigative dermatology (01.11.2023)
Get full text
Journal Article